Search Results

• • 57 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Challenges and opportunities for modeling aging and cancer.

  Authors:Olga Anczuków, Susie Airhart, Jeffrey H. Chuang, Lisa M. Coussens, George A. Kuchel, Ron Korstanje, et al.From:Cancer Cell (Vol. 41, Issue 4) Peer-Reviewed

  Apr. 10, 2023338 words Brief article

   Abstract Only

• Neutralizing tumor-promoting chronic inflammation: a magic bullet?

  Authors:Lisa M. Coussens, Laurence Zitvogei, and A. Karolina PaluckaFrom:Science (Vol. 339, Issue 6117) Peer-Reviewed

  Jan. 18, 2013121 words Author abstract, Rep...

   Abstract Only

• B regulatory cells and the tumor-promoting actions of TNF-[alpha] during squamous carcinogenesis.

  Authors:Tiziana Schioppa, Robert Moore, Richard G. Thompson, Elizabeth C. Rosser, Hagen Kulbe, Sergei Nedospasov, et al.From:Proceedings of the National Academy of Sciences of the United States (Vol. 108, Issue 26) Peer-Reviewed

  June 28, 2011196 words Report, Author abstr...

   Abstract Only

• TIM-3 Regulates CD103.sup.+ Dendritic Cell Function and Response to Chemotherapy in Breast Cancer

  Authors:Alvaro de Mingo Pulido, Alycia Gardner, Shandi Hiebler, Hatem Soliman, Hope S. Rugo, Matthew F. Krummel, et al.From:Cancer Cell (Vol. 33, Issue 1) Peer-Reviewed

  Jan. 8, 2018328 words Report

   Abstract Only

• B cells as biomarkers: predicting immune checkpoint therapy adverse events

  Authors:Shannon M. Liudahl and Lisa M. CoussensFrom:Journal of Clinical Investigation (Vol. 128, Issue 2) Peer-Reviewed

  Feb. 20182,564 words Report 1600LImmune checkpoint inhibitors are becoming a cornerstone of cancer immunotherapy as a result of their clinical success in relieving immune suppression and driving durable antitumor T cell responses in certain subsets of...

• Complement C5a Fosters Squamous Carcinogenesis and Limits T Cell Response to Chemotherapy

  Authors:Terry R. Medler, Dhaarini Murugan, Wesley Horton, Sushil Kumar, Tiziana Cotechini, Alexandra M. Forsyth, et al.From:Cancer Cell (Vol. 34, Issue 4) Peer-Reviewed

  Oct. 8, 2018346 words Report

   Abstract Only

• Matrix metalloproteinase-2 and -9 expression increases in Mycoplasma-infected airways but is not required for microvascular remodeling

  Authors:Peter Baluk, Wilfred W. Raymond, Erin Ator, Lisa M. Coussens, Donald M. McDonald, and George H. CaugheyFrom:American Journal of Physiology (Consolidated) (Vol. 287, Issue 2) Peer-Reviewed

  Aug. 2004277 words Author abstract

   Abstract Only

• Matrix metalloproteinase inhibitors and cancer: trials and tribulations. (Review: Cancer Therapy)

  Authors:Lisa M. Coussens, Barbara Fingleton, and Lynn M. MatrisianFrom:Science (Vol. 295, Issue 5564) Peer-Reviewed

  Mar. 29, 20025,106 words Article For at least 30 years, matrix metalloproteinases (MMPs) have been heralded as promising targets for cancer therapy on the basis of their massive up-regulation in malignant tissues and their unique ability to degrade all...

• Differential macrophage programming in the tumor microenvironment

  Authors:Brian Ruffell, Nesrine I. Affara, and Lisa M. CoussensFrom:Trends in Immunology (Vol. 33, Issue 3) Peer-Reviewed

  Mar. 2012 Report

   Citation Only

• Macrophages and Therapeutic Resistance in Cancer

  Authors:Brian Ruffell and Lisa M. CoussensFrom:Cancer Cell (Vol. 27, Issue 4) Peer-Reviewed

  Apr. 13, 2015142 words Article

   Abstract Only

• Macrophages and Metabolism in the Tumor Microenvironment

  Authors:Ilio Vitale, Gwenola Manic, Lisa M. Coussens, Guido Kroemer, and Lorenzo GalluzziFrom:Cell Metabolism (Vol. 30, Issue 1) Peer-Reviewed

  July 2, 2019338 words Report

   Abstract Only

• Ibuprofen supports macrophage differentiation, T cell recruitment, and tumor suppression in a model of postpartum breast cancer

  Authors:Nathan D. Pennock, Holly A. Martinson, Qiuchen Guo, Courtney B. Betts, Sonali Jindal, Takahiro Tsujikawa, et al.From:Journal for ImmunoTherapy of Cancer (Vol. 6, Issue 1) Peer-Reviewed

  Oct. 1, 201812,975 words Report 1690LBackground Women diagnosed with breast cancer within 5 years postpartum (PPBC) have poorer prognosis than age matched nulliparous women, even after controlling for clinical variables known to impact disease outcomes....

• Workshop on challenges, insights, and future directions for mouse and humanized models in cancer immunology and immunotherapy: a report from the associated programs of the 2016 annual meeting for the Society for Immunotherapy of cancer

  Authors:Andrew Zloza, A. Karolina Palucka, Lisa M. Coussens, Philip J. Gotwals, Mark B. Headley, Elizabeth M. Jaffee, et al.From:Journal for ImmunoTherapy of Cancer (Vol. 5, Issue 1) Peer-Reviewed

  Sept. 19, 20175,579 words Article 1560LUnderstanding how murine models can elucidate the mechanisms underlying antitumor immune responses and advance immune-based drug development is essential to advancing the field of cancer immunotherapy. The Society for...

• Inflaming Gastrointestinal Oncogenic Programming

  Authors:David G. DeNardo, Magnus Johansson, and Lisa M. CoussensFrom:Cancer Cell (Vol. 14, Issue 1) Peer-Reviewed

  July 8, 2008147 words Report

   Abstract Only

• Inflammation, proteases and cancer

  Authors:LeOn C.L. Van Kempen, Karin E. De Visser, and Lisa M. CoussensFrom:European Journal of Cancer (Vol. 42, Issue 6) Peer-Reviewed

  Apr. 2006279 words Report

   Abstract Only

• The tumor microenvironment: a critical determinant of neoplastic evolution

  Authors:LeOn C.L.T. Van Kempen, Dirk J. Ruiter, Goos N.P. Van Muijen, and Lisa M. CoussensFrom:European Journal of Cell Biology (Vol. 82, Issue 11) Peer-Reviewed

  Nov. 2003262 words Report

   Abstract Only

• Cathepsin C is a tissue-specific regulator of squamous carcinogenesis

  Authors:Brian Ruffell, Nesrine I. Affara, Lucia Cottone, Simon Junankar, Magnus Johansson, David G. DeNardo, et al.From:Genes & Development (Vol. 27, Issue 19) Peer-Reviewed

  Oct. 1, 2013 Report

   Citation Only

• Multiplex immunohistochemistry for immune profiling of HPV-associated head and neck cancer

  Authors:Takahiro Tsujikawa, Rohan N Borkar, Vahid Azimi, El Edward Rassi, Daniel R Clayburgh, Sushil Kumar, et al.From:Journal for ImmunoTherapy of Cancer (Vol. 3, Issue Suppl 2) Peer-Reviewed

  Nov. 4, 2015583 words Author abstract, Rep... 1800LAuthor(s): Takahiro Tsujikawa1 , Rohan N Borkar2 , Vahid Azimi2 , El Edward Rassi1 , Daniel R Clayburgh1 , Sushil Kumar1 , Andrew J Gunderson1 , Molly F Kresz-Martin1 , Paul W Flint1 and Lisa M Coussens1 Human...

• Robust Cell Detection and Segmentation for Image Cytometry Reveal Th17 Cell Heterogeneity

  Authors:Ewert Bengtsson, Attila Tarnok, Takahiro Tsujikawa, Guillaume Thibault, Vahid Azimi, Sam Sivagnanam, et al.From:Cytometry Part A (Vol. 95, Issue 4) Peer-Reviewed

  Apr. 20191,035 words Article

   Abstract Only

• Mammary Gland Involution as an Immunotherapeutic Target for Postpartum Breast Cancer

  Authors:Jaime Fornetti, Holly A. Martinson, Courtney B. Betts, Traci R. Lyons, Sonali Jindal, Qiuchen Guo, et al.From:Journal of Mammary Gland Biology and Neoplasia (Vol. 19, Issue 2) Peer-Reviewed

  July 2014340 words Report

   Abstract Only